Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
04/2009
04/21/2009US7521437 7-phenyl-substituted tetracycline compounds
04/16/2009WO2009047615A2 Novel histone deacetylase inhibitors
04/16/2009WO2009047319A1 Contrast agents
04/16/2009WO2009047318A1 Contrast agents
04/16/2009WO2009047317A1 Contrast agents
04/16/2009WO2009047316A1 Contrast agents
04/16/2009WO2009047315A1 Contrast agents
04/16/2009WO2006132959A3 Inhibition of thrombin generation
04/16/2009US20090099376 Tigecycline and methods of preparing intermediates
04/16/2009US20090098059 Contrast agents
04/16/2009US20090097026 Color measurements of reconstituted tigecycline and degradant thereof
04/16/2009US20090095681 P-tert-butylcalix[6]arenes with triacidic functions at 2, 4 and 6, supported liquid membranes and support materials comprising the same and use thereof
04/16/2009DE102007049039A1 Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung Process for the preparation of 8-hydrazino-8-aryl-Octanoylderivaten and their use
04/16/2009CA2702536A1 Novel histone deacetylase inhibitors
04/15/2009EP2046765A1 Insecticidal compounds
04/15/2009CN101407473A Method for recycling abricycline from abricycline crystal mother liquor
04/15/2009CN101407453A A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
04/14/2009US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis
04/09/2009US20090093664 Carbon nanotubes using for recovery of radionuclides and separation of actinides and lanthanides
04/09/2009US20090093534 Mu opioid receptor ligands: methods of use and synthesis
04/09/2009US20090093388 Novel acyl group-containing composition
04/08/2009EP2044006A1 Insecticidal compounds
04/08/2009EP2044005A2 Prolyl hydroxylase inhibitors and methods of use
04/08/2009EP2044002A2 Process for making 3-substituted 2-amino-5-halobenzamides
04/08/2009CN101402706A Method for preparing tsiklomitsin molecular engram polymer used for water environment
04/08/2009CN100475786C 4-hydroxy valeramide compounds, prepn. method and use thereof
04/08/2009CN100475777C Amide type carboxamide derivative
04/08/2009CN100475776C Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents
04/07/2009US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
04/07/2009US7514582 Cardiac ANTIARRHYTHMIA AGENTS; atrial fibrillation or atrial flutter; Kv1.5 potassium channel blockers;
04/02/2009WO2008128207A9 Alpha-galactosyl ceramide analogs and their use as immunotherapies
04/02/2009US20090088571 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
04/02/2009US20090088480 Solid forms of selective androgen receptor modulators
04/02/2009US20090088479 Salt of aliskiren with sulfuric acid
04/02/2009US20090088478 Novel compounds as histone deacetylase inhibitors
04/01/2009EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases
04/01/2009EP2040688A1 New cxcr2 inhibitors
04/01/2009CN101397355A Method for preparing molecular imprinting polymer capable of identifying oxytetracycline and enrofloxacin
04/01/2009CN100473644C 9-substituted minocycline compounds
03/2009
03/31/2009US7511074 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke
03/31/2009US7511043 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids
03/31/2009CA2226894C 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
03/26/2009WO2009038038A1 Acetylene compound, salt thereof, condensate thereof, and composition thereof
03/26/2009WO2009037707A2 N-phenyl anthranilic acid derivatives and uses thereof
03/26/2009WO2009037229A1 Process for the manufacture of bridged monobactam intermediates
03/26/2009US20090082465 Deuterium-enriched lisdexamfetamine
03/26/2009US20090082458 Deuterium-enriched aliskiren
03/26/2009US20090082328 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
03/25/2009EP2039689A1 Process for production of optically active 3-amino-2 -hydroxypropionic cyclopropylamide derivatives and salts thereof
03/25/2009EP1296935B1 Process for the preparation of substituted octanoyl amides
03/24/2009US7507765 Mevalonic acid derivatives; antitumor/anticancer agents
03/24/2009US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery
03/24/2009CA2176373C Farnesyl derivatives and pharmaceutical compositions containing them
03/19/2009US20090076304 Methods for producing carboxylic acid chloride compounds
03/19/2009US20090076154 Deuterium-enriched vorinostat
03/19/2009US20090076115 Photosensitizers for Targeted Photodynamic Therapy
03/19/2009US20090074673 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
03/18/2009EP2035367A1 Ship 1 modulator prodrugs
03/18/2009EP0872481B1 Depsipeptide derivative, process for production thereof, and novel intermediate therefor
03/18/2009CN101389598A Aliskiren nitrate salt
03/18/2009CN101386582A Tigecycline and preparation method thereof
03/17/2009US7504538 4-[3-phenyl-1-(6-phenylhexyl)ureido]butyramide; cannabinoid receptor modulators
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/17/2009US7504364 Methods of making arrays and artificial receptors
03/17/2009CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
03/12/2009WO2009030962A1 Bicyclic aryl and heteroaryl receptor modulators
03/12/2009WO2009030457A1 Novel processes and compounds
03/12/2009US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
03/12/2009US20090069431 Deuterium-enriched milnacipran
03/12/2009US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt
03/12/2009CA2698847A1 Bis-aromatic compounds useful in the treatment of inflammation
03/11/2009EP2033950A1 Substituted tetracycline compounds
03/11/2009EP2032535A1 Spirocyclic nitriles as protease inhibitors
03/11/2009CN100467450C Anthranilic acid amides and pharmaceutical use thereof
03/10/2009US7501538 Erythropoietin receptor activators; inducing red blood cell production and maturation
03/05/2009WO2009028824A2 A novel cationic lipid, a preparation method of the same and a delivery system comprising the same
03/05/2009WO2009027450A1 Novel bradykinin b1-antagonists
03/05/2009US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
03/05/2009US20090060917 methyl [2-hydroxy-5-[1-hydroxy-2-[[(2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-phenyl] carbamate; water-stable, long acting beta 2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like
03/05/2009US20090060838 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
03/05/2009CA2697946A1 New bradykinin b1-antagonists
03/04/2009EP0869974B1 Compounds with growth hormone releasing properties
03/04/2009CN101379036A Anthranilamide/2-amino-heteroarene carboxamide derivatives
03/04/2009CN101379029A A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
03/04/2009CN101379023A Contrast agents
03/04/2009CN101376638A Method for separating and purifying glutamine and aminoglutaric acid from glutamine fermentation liquor
03/03/2009US7498292 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
02/2009
02/26/2009WO2009023964A1 Renin inhibitors
02/26/2009WO2008156701A3 Hydroxamate inhibitors of insulin-degrading enzyme and uses thereof
02/26/2009US20090054312 SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases
02/26/2009US20090053142 Contrast agents
02/26/2009CA2696689A1 Renin inhibitors
02/25/2009EP2027083A1 Method of preparing chiral cyclic beta-aminocarboxamides
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/24/2009CA2444208C Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
02/24/2009CA2355888C Blood pool agents for nuclear magnetic resonance diagnostics
02/19/2009US20090048226 Inhibitors of caspases
02/19/2009US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation
02/18/2009EP2025661A1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof
02/18/2009EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 162